Antifilarial agents

Expert Opinion on Therapeutic Patents

Volumn 17, Issue 7, 2007, Pages 767-789

  Mathew, Nisha ^a   Kalyanasundaram, Muthuswami ^a  

^a VECTOR CONTROL RESEARCH CENTRE   (India)

Author keywords

Albendazole; Antifilarial; Chemotherapy; Diethylcarbamazine; Filariasis; Ivermectin; Wolbachia

Indexed keywords

4 (7 CHLORO 4 QUINOLYLAMINO) 3 ISOPROPYLAMINOMETHYLPHENOL; 7 CHLORO 4 [[4 (DIETHYLAMINO)CYCLOHEXYL]AMINO]QUINOLINE; ALBENDAZOLE; AMOCARZINE; AMODIAQUINE; AMOSCANATE; ANTHRAQUINONE DERIVATIVE; ANTIFILARIAL AGENT; ANTIMYCIN A1; ANTINEMATODAL AGENT; BENZIMIDAZOLE DERIVATIVE; CENTPERAZINE; CHLOROQUINE; CLOFAZIMINE; DEETHYLCHLOROQUINE; DIETHYLCARBAMAZINE; DOXYCYCLINE; FLUBENDAZOLE; FOSMIDOMYCIN; IVERMECTIN; MEBENDAZOLE; MEPACRINE; METOBETHIAMIDE; METRIFONATE; MOXIDECTIN; PRIMAQUINE; QUININE; SONTOQUINE; SURAMIN; UNINDEXED DRUG;

BLOOD DYSCRASIA; BRUGIA; BRUGIA MALAYI; BRUGIA TIMORI; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE TRANSMISSION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG STRUCTURE; DRUG SYNTHESIS; FILARIASIS; HUMAN; INJECTION SITE ABSCESS; LOW DRUG DOSE; MONOTHERAPY; MORBIDITY; MOSQUITO; NEMATODE; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; REPEATED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; WUCHERERIA BANCROFTI;

EID: 34547891912     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.17.7.767     Document Type: Review

References (125)

1. WHO REPORT: WHO/TDR Scientific Working Group on 'RNA Interference as a Means of Identifying Drug Targets for Filariasis'. WHO, Geneva (2003):1-15.
2. WORLD HEALTH REPORT: Reducing Risks and Promoting Healthy Life. WHO, Geneva (2002).
3. HALL LR, PEARLMAN E. Pathogenesis of onchocercal keratitis (river blindness) Clin. Microbiol. Rev. (1999) 12(3):445-453.
4. WORLD HEALTH ORGANISATION: Lymphatic Filariasis: The Disease and Its Control. WHO, Geneva (1992).
5. EDESON JFB, WHARTON RH: The experimental transmission of Wuchereria infections from man to animals. In: Proc. 6th Int. Cong. Trop. Med. Mal. (Lan& Lisbon) (1959):466-471.
6. ASH LR, SCHACHER JF: Early life-cycle and larval morphogenesis of Wuchereria bancrofti in the jird, Meriones unguiculatus. J. Parasital. (1971) 57:1043-1051.
7. AMARAL F, DREYER G, FIGUEREDO-SILVA J et al.: Live adult worms detected by ultrasonography in human bancroftian filariasis. Am. J. Trop. Med. Hyg. (1994) 50:753-757.
8. SCHACHER JF: Morphology of the microfilariae of Brugia pahangi and the larval stages in mosquito. J. parisitol. (1962) 48:679-692.
9. MOLYNEUX DH, BRADLEY M, HOERAUF A et al.: Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol. (2003) 19(11):516-522.
10. REE GH: Onchocerciasis treated with diethylcarbamazine. Br. J. Dermatol. (1977) 97:551-554.
11. TAYLOR HR, GREENE BM, LANGHAM ME: Controlled clinical trial of oral and topical diethylcarbamazine in the treatment of onchocerciasis. Lancet (1990) 1:943-946.
12. AWADZI K, GILLES HM: Diethylcarbamazine in the treatment of patients with onchocerciasis. Brit. J. Clin. Pharmacol. (1992) 34:281-288.
13. VAN LAETHEM Y, LOPECS C: Treatment of onchocerciasis. Drugs (1996) 52:861-869.
14. WHO EXPERT COMMITTEE ON ONCHOCERCIASIS CONTROL: Onchocerciasis and its control. World Health Organ. Tech. Rep. Ser. (1995) 852:50-57.
15. HEWITT RI, WHITE E, WALLACE WS et al.: Experimental chemotherapy of filariasis 2. Effect of piperazine derivatives against naturally acquired filarial infections in cotton rats and dogs. J. Lab. Clin. Med. (1947) 32:304-1313.
16. SANTIAGO-STEVENSON D, OLIVER-GONZALEZ J, HEWITT RI: Treatment of Filariasis bancrofti with 1-diethylcarbamyl-4-methylpiperazine hydrochloride (Hetrazan). J. Am. Med. Assoc. (1947) 135:708-712.
17. HAWKING F: Diethylcarbamazine: a review of literature with special reference to its pharmacodynamics, toxicity, and use in the therapy of onchocerciasis and other filarial infections. WHO/ONCHO/78 (1978):142.
18. MITSUI Y, AOKI Y. A direct competitive ELISA for the simple, sensitive and accurate determination of diethylcarbamazine concentration in serum. Int. J. Parasitol. (1998) 28:623-626.
19. MELROSE W: Lymphatic filariasis: a review 1862-2002. Warwick Educational Publishing Inc., Australia (2004):1-80.
20. WEIL GJ, LAMMIE PJ, RICHARDS FO et al.: Changes in circulating parasite antigen levels after treatment of Bancroftian filariasis with diethylcarbamazine. J. Infect. Dis. (1991) 164:814-816.
21. ISMAIL MM, WEIL GJ, JAYASINGHE KS et al.: Prolonged clearance of microfilaremia in patients with Bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine. Trans. R. Soc. Trop. Med. Hyg. (1996) 90:684-688.
22. DREYER G, ADDISS D, SANTOS A et al.: Direct assessment in vivo of the efficacy of combined single-dose ivermectin and diethylcarbamazine against adult Wuchereria bancrofti. Trans. R. Soc. Trop. Med. Hyg. (1998) 92(2):219-222.
23. DREYER G, NOROES J, AMARAL F et al.: Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasis. Trans. R. Soc. Trop. Med. Hyg. (1995) 89:441-443.
24. MCCARTHY JS, GUINEA A, WEIL GJ et al.: Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection. J. Infect. Dis. (1995) 172(2):521-526.
25. DREYER G, ADDISS D, WILLIAMSON J et al.: Efficacy of co-administered diethylcarbamazine and albendazole against adult Wuchereria bancrofti. Trans. R. Soc. Trop. Med. Hyg. (2006) 100(12):1118-1125.
26. FUJIMAKI Y, SITHITHAWORN P, MITSUI Y et al.: Delayed macrofilaricidal activity of diethylcarbamazine against Brugia pahangi in Mongolian jirds. J. Helminthol. (2004) 78(4):293-295.
27. HUSSEIN O, SETOUHY ME, AHMED ES et al.: Duplex doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in bancroftian filariasis. Am. J. Trop. Med. Hyg. (2004) 71(4):471-477.
28. PEIXOTO CA, ROCHA A, AGUIAR-SANTOS A et al.:The effects of diethylcarbamazine on the ultra structure of microfilariae of Wichereria bancrofti in vivo and in vitro. Parasitol. Res. (2004) 92(6):513-517.
29. MAK JW: Antifilarial compounds in the treatment and control of lymphatic filariasis. Trop. Biomed. (2004) 21(2):27-38.
30. GREENE BM, TAYLOR HR, CUPP EW et al.: Controlled comparison of ivermectin and diethylcarbamazine in treatment of human onchocerciasis. N. Engl. J. Med. (1985) 313:133-138.
31. CUPP EW, CUPP MS: Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. Am. J. Trop. Med. Hyg. (2005) 73(6):1159-1161.
32. GOA KL, MCTAVISH D, CLISSOLD SP: Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficiency in Onchocerciasis. Drugs (1991) 42:640-658.
33. NGUYEN NL, MOULIA-PELAT JP, CARTEL JL: Control of lymphatic filariasis in an endemic area of Polynesia by ivermectin 400 micrograms/kg. Trans. R. Soc. Trop. Med. Hyg. (1996) 90:689-691.
34. SHENOY RK, KUMARASWAMI V, RAJAN K et al.: A comparative study of the efficacy and tolerability of single and split doses of ivermectin and diethylcarbamazine in periodic brugian filariasis. Ann. Trop. Med. Parasitol. (1993) 87(5):459-467.
35. PLAISIER AP, CAO WC, VAN OORTMARSSEN GJ et al.: Efficacy of ivermectin in the treatment of Wuchereria bancrofti infection: a model-based analysis of trial results. Parasitology (1999) 119:385-394.
36. DREYER G, ADDISS D, NOROES J et al.: Ultrasonic assessment of the adulticidal efficacy of repeat high-dose ivermectin in Bancroftian filariasis. Trop. Med. Int. Health (1996) 1:427-432.
37. NICKEL P, HAACK HJ, WIDJAJA H: Potential filaricides; Suramin analogues. Drug Res. (1986) 36:1153-1157.
38. GOODWIN IG: Recent advances in research on filariasis. Chemotherapy. Trans. R. Soc. Trop. Med. Hyg. (1984) 78(Suppl.):1-8.
39. AWADZI K: Clinical picture and outcome of serious adverse events in the treatment of onchocerciasis. Filaria J. (2003) 2(1):S6.
40. MCCARTHY J: Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis? Am. J. Trop. Med. Hyg. (2005) 73(2):232-233.
41. STURM P, HENRY DW, THOMPSON PE: Antifilarial agents. Diazabicyclooctanes and diazabicycloheptanes as bridged analogs of diethylcarbamazine. J. Med. Chem. (1974) 17(5):481-487.
42. STURM P, CORY M, HENRY DW et al.: Antifilarial agents. 1,2-cyclobutanediamines as analogues of diethylcarbamazine. status of structure-activity relationships among diethylcarbamazine analogues. J. Med. Chem. (1977) 20(10):1327-1333.
43. STURM P, CORY M, HENRY DW: Antifilarial agents. 3-Aminopyrrolidine and 1,4-diazabicyclo [3.2.1] octane derivatives as analogues of diethylcarbamazine. J. Med. Chem. (1977) 20(10):1333-1337.
44. SAXENA R, SHARMA S, IYER RN, ANAND N: Studies in potential filaricides. 5, 3-Ethyl-8-methyl-1, 3, 8-triazabicyclo [4, 4, 0] decan-2-one, a new antifilarial agent. J. Med. Chem. (1971) 14:929-930.
45. THOMPSON PE, ZEIGLER JB, MCCALL JW: Comparative effects of 3-ethyl-8-methyl-1, 3, 8-triazabicyclo [4, 4, 0] decan-2-one and diethylcarbamazine against Litomosoides carinii in rodents. Antimicrob. Agents Chemother. (1973) 3(6):693-697.
46. WHO Scientific Working Group on Filariasis Report No. TDR/Filsing (3) 79.3 (1979).
47. KERCKHOVEN VI, KUMAR V: Macrofilaricidal activity of oral flubendazole on Brugia pahangi. Trans. R. Soc. Trop. Med. Hyg. (1988) 82:890-891.
48. DENHAM DA, BRANDT E: Chemoprophylactic activity of flubendazole against adult Brugia pahangi transplanted into the peritoneal cavity of jirds. J. Pararitol. (1980) 66:933-934.
49. RIVAS-ALCALA R, MACKENZIE CD, GOMEZ-ROJO E et al.: The effects of diethylcarbamazine and levamisole on Onchocerca volvulus in vivo and in vitro. Trop. Med. Parasitol. (1984) 35:71-77.
50. DOMINGUEZ-VANQUEZ A, TAYLOR HR, GREENE BM et al.: Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis. Lancet (1983) 1:139-143.
51. FRIEDMAN PA, PLATZER EG: Interaction of anthelmintic benzimidazoles with Ascaris suum embryonic tubulin. Biochim. Biophys. Acta (1980) 630:271-278.
52. LACEY E: The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int. J. Parasitol. (1988) 18: 885-936.
53. RAM S, WISE DS, WOTRING LL et al.: Synthesis and biological activity of certain alkyl 5-(alkoxycarbonyl)-1H-benzimidazole-2-carbamates and related derivatives: a new class of potential antineoplastic and antifilarial agents. J. Med. Chem. (1992) 35(3):539-547.
54. ABUZAR S, SHARMA S, FATMA N et al.: Studies in potential filaricides. 18. Synthesis of 2, 2′-disubstituted 5, 5′-dibenzimidazolyl ketones and related compounds as potential anthelmintics. J. Med. Chem. (1986) 29:1296-1299.
55. FATMA N, SHARMA S, CHATTERJEE RK: 2, 2′-Dicarbomethoxyamino-5, 5′-dibenzimidazolyl ketone - a new antifilarial agent. Acta Trop. (1989) 46(5-6):311-321.
56. DUBEY R, ABUZAR S, SHARMA S et al.: Synthesis and anthelmintic activity of 5(6)-(benzimidazol-2-ylcarbamoyl) and (4-substituted piperazin-1-yl) benzimidazoles. J. Med. Chem. (1985) 28:1748-1750.
57. KUMAR S, SETH M, BHADURI AP et al.: Syntheses and anthelmintic activity of alkyl 5(6)-(substituted-carbamoyl)- and 5(6)-(disubstituted-carbamoyl) benzimidazole-2-carbamates and related compounds. J. Med. Chem. (1984) 27:1083-1089.
58. RAM S, SKINNER M, KALVIN D et al.: Synthesis of potential antifilarial agents. 1. 1-(5-Benzoylbenzimidazol-2-yl)-3-alkyl and arylureas. J. Med. Chem. (1984) 27:914-917.
59. ANDERSON RJ, BENDELL DJ, HOOPER M et al.: Potential transition state phosphoramidate inhibitors of β-tubulin as antifilarial agents. J. Pharm. Pharmacol. (2001) 53:89-94.
60. 4-phenyl-2,4-quinazoline diamines as potential antifilarial agents. J. Med. Chem. (1983) 26:1311-1316.
61. KUMAR Y, GREEN R, WISE DS et al.: Synthesis of 2,4-disubstituted thiazoles and selenazoles as potential antifilarial and antitumor agents. 2. 2-Arylamido and 2-alkylamido derivatives of 2-amino4-(isothiocyanatomethyl) thiazole and 2-ammo-4-(isothiocyanatomethyl) selenazole. J. Med. Chem. (1993) 36:3849-3852.
62. KUMAR Y, GREEN R, BORYSKO KZ et al.: Synthesis of 2, 4-disubstituted thiazoles and selenazoles as potential antitumor and antifilarial agents. 1. Methyl 4-(isothiocyanatomethyl) thiazole-2-carbamates,-selenazole-2-carbamates, and related derivatives. J. Med. Chem. (1993) 36:3843-3848.
63. CHAUHAN PMS, CHATTERJEE RK: Antifilarial profile of pyrazoles. CSIR Golden Jubilee Symposium on Tropical Diseases; Molecular Biology and Control Strategies. Lucknow, 17-20 February (1992):34-39.
64. CHAUHAN PMS, CHATTERJEE RK: Synthesis of 1, 3-substituted indoles, 2, 4, 6-substituted-s-triazines and 4, 5-substituted pyrazoles as possible antifilarial agents. Indian J. Chem. (1994) 33B:32-37.
65. SRIVASTAVA SK, AGARWAL A, CHAURAN PMS et al.: Potent 1, 3-disubstituted-9H-pyrido [3, 4-b] indoles as new lead compounds in antifilarial chemotherapy. Bioorg. Med. Chem. (1999) 7:1223-1236.
66. KAZLAUSKAS R, MURPHY PT, QUINN RJ, WELLS RJ: Aplysinopsin a new tryptophan derivative from a sponge. Tetrahedron Lett. (1977) 18(1):61-64.
67. HOLLENBEAK KH, SCHMITZ FJ: Aplysinopsin: antineoplastic tryptophan derivative from the marine sponge Verongia spengelii. Lloydia (1977) 40(5):479-481.
68. SINGH SN, BHATNAGAR S, FATMA N et al.: Antifilarial activity of a synthetic marine alkaloid, aplysinopsin (CDRI Compound 92/138). Trop. Med. Int. Health (1997) 2(6):535-543.
69. SANGER I, LAMMLER G, WEGERHOF PH: The efficacy of amoscanate (C9333-Go/ CGP 4540) on filarial infections of Mastomys natalensis. Acta Trop. (1980) 37(3):262-265.
70. ZAHNER H, SCHARES G. Experimental chemotherapy of filariasis: comparative evaluation of the efficacy of filaricidal compounds in Mastomys coucha infected with Litomosoides carinii, Acanthocheilonema viteae, Brugia malayi and B. pahangi. Acta Trop. (1993) 52(4):221-266.
71. ZEA-FLORES G, BELTRANENA F, POLTERA AA: Amocarzine investigated as oral onchocercacidal drug in 272 adult male patients from Guatemala. Results from three dose regimens spread over three days. Trop. Med. Parasitol. (1991) 42(3):240-262.
72. KOHLER P, DAVIES KP, ZAHNER H: Activity, mechanism of action and pharmacokinetics of 2-tert-butylbenzothiazole and CGP 6140 (amocarzine) antifilarial drugs. Acta Trop. (1992) 51(3-4):195-211.
73. CHANDRASHEKAR R, SUBRAHMANYAM D, WEIL GJ: Effect of CGP 20376 on Brugia malayi and parasite antigenemia in Jirds. J. Parasitol. (1991) 77(3):479-482.
74. SUNDBERG RJ, BISWAS S, MURTHI KK et al.: Bis-cationic heteroaromatics as macrofilaricides: synthesis of bis-amidine and bis-guanylhydrazone derivatives of substituted imidazo [1, 2-a] pyridines J. Med. Chem. (1998) 41(22):4317-4328.
75. TRIPATHI RP, TRIPATHI R, BHADURI AP et al.: Antifilarial activity of some 2H-1-benzopyran-2-ones (coumarins). Acta Trop. (2000) 76(2):101-106.
76. TRIPATHI RP, TIWARI VK, BRATTACHARYA SM et al.: 7-O-[4-methyl piperazine-1-(2-aceryl)]-2H-1-benzopyran-2-one: a novel antifilarial lead compound. Acta Trop. (2003) 87(2):215-224.
77. KATIYAR D, TIWARI VK, TRIPATHI RP et al.: Synthesis and antifilarial evaluation of 7-O-acetamidyl-4-alkyl-2H-1-benzopyran-2-ones. Arzneimittelforschung (2003) 53(12):857-863.
78. BHATTACHARYA SM, KATIYAR D, BAJPAI P et al.: 4-Methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one: a novel DNA topoisomerase II inhibitor with adulticidal and embryostatic activity against sub-periodic Brugia malayi. Parasitol. Res. (2004) 92:177-182.
79. BRIENNE MJ, VARECH D, LECLERCQ M et al.: New antifilarial agents. 1. Epoxy sulfonamides and ethynesulfonamides. J. Med. Chem. (1987) 30(12):2232-2239.
80. BUEDING E: Studies on the metabolism of the filarial worm, Liotmosoides carinii. J. Exp. Med. (1949) 89:107-130.
81. PETERS L, BUEDING E, VALK AD et al.: The antifilarial action of cyanine dyes: 1. The relative antifilarial activity of a series of cyanine dyes against Litomosoide carinii in vitro and in the cotton rat. J. Pharmacol. Exp. Ther. (1949) 95:212-239.
82. PETERS L, WELCH AD, HIGASHI A: The antifilarial action of cyanine dyes II. Selection of 1′-ethyl-3, 6-dimethyl-2-phenyl-4-pyrimido-2′-cyanine chloride (# 863) for further study as a potential antifilarial agent. J. Pharmacol. Exp. Ther. (1949) 96(4):460-471.
83. ANGELO MM, ORTWINE D, WORTH DF et al.: Synthesis and antifilarial activity of N-[4- [4-alkoxy-3-[(dialkylamino)m ethyl]phenyl]amino]- 2-pyrimidinyl]-N'-phenylguanidines. J. Med. Chem. (1983) 26:1258-1267.
84. NISHA M, PAILY KP, VANAMAIL P et al.: Macrofilaricidal activity of the plant Plumbago indica/rosea in vitro. Drug Dev. Res. (2002) 56(1):33-39.
85. NISHA M, KALYANASUNDARAM M, BALARAMAN K: Glutathione S-transferase (GST) inhibitors. Expert Opin. Ther. Patents (2006) 16(4):431-444.
86. NATHAN ST, NISHA M, KALYANASUNDARAM M, BALARAMAN K: Structure of glutathione S-transferase of the filarial parasite Wuchereria bancrofti - a target for drug development against adult worm. J. Mol. Model. (2005) 11(3):194-199.
87. n-xylofuranosylated diaminoalkanes. Bioorg. Med. Chem. (2003) 11(8):1789-1800.
88. SRIVASTAVA SK, CHAUHAN PMS, BHADURI AP et al.: Secondary amines as new pharmacophores for macrofilaricidal drug design. Bioorg. Med. Chem. Lett. (2000) 10:313-314.
89. SALAZAR MM, GONZALEZ BD, ALVAREZ FG: Onchocerca dermatosis from Mexico and its therapy with metrifonate. Trop. Med. Parasitol. (1970) 21(3):213-219.
90. THOMPSON PE, BOCHE L, BLAIR LS: Effects of amodiaquine against Litomosides carinii in gerbils and cotton rats. J. Parasitol. (1968) 54(4):834-837.
91. MCMAHON JE: Preliminary screening of antifilarial activity of levamisole and amodiaquine on Wuchereria bancrofti. Ann. Trop. Med. Parasitol. (1979) 73(5):465-472.
92. MEI-LIN G, TONG-LAN N, ALFRED SCW: Synthesis of some novel amodiaquine analogues as potential antimalarial and antifilarial compounds. J. Med. Chem. (1981) 24:1471-1475.
93. ELSLAGER EF, PERRICONE SC, TENDICK FH: Antifilarial agents. I. Effects of 4-[(7-chloro-4-quinolyl)-amino]-α-(mono- and dialkylamino)-α-cresols and related compounds against Litornosoides carinii in gerbils. J. Med. Chem. (1969) 12(6):965-969.
94. VANDEWAA EA, BENNETT JL, WILLIAMS JF et al.: Anti-filarial effects of nine quinoline-containing drugs on adult filariae in vitro. J. Parasitol. (1989) 75(3):367-372.
95. SRIVASTAVA SK, HAQ W, MURTHY PK, CHAUHAN PMS: Solid phase synthesis of quinolones. Bioorg. Med. Chem. Lett. (1999) 9(14):1885-1888.
96. SRIVASTAVA SK, CHAUHAN PMS, BHADURI AP et al.: Quinolones: novel probes in antifilarial chemotheraphy. J. Med. Chem. (2000) 43(11):2275-2279.
97. SELWOOD DL, LIVINGSTONE DJ, COMLEY JCW et al.: Structure-activity relationships of antifilarial antimycin analogues: a multivariate pattern recognition study. J. Med. Chem. (1990) 33:136-142.
98. TAGBOTO S, TOWNSON S: Antiparasitic properties of medicinal plants and other naturally occurring products. Adv. Parasitol. (2001) 50:199-295.
99. TREES AJ, TREES AJ, GRAHAM SP et al.: Onchocerca ochengi infections in cattle as model for human onchocerciasis: recent developments. Parasitology (2000) 120:S133-S142.
100. CHATTERJEE RK, FATMA N, MURTHY PK et al.: Macrofilaricidal activity of the stembark of Streblus asper and its major active constituents. Drug Dev. Res. (1992) 26:67-78.
101. SHARMA S: Advances in the treatment and control of tissue-dwelling helminth parasites. Prog. Drug Res. (1986) 30:473-547.
102. DENHAM DA, MIDWINTER IT, FRIEDHEIM EA: The anthelmintic activity of a novel organic arsenical, R7/45, upon Brugia pahangi in Meriones unguiculatus. J. Helminthol. (1990) 64(2):100-104.
103. TAYLOR MJ, HOERAUF A: Wolbachia bacteria of filarial nematodes. Parasitol. Today (1999) 15(11):437-442.
104. HOERAUF A, NISSEN-PÄHLE K, SCHMETZ C et al.: Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. J. Clin. Invest. (1999) 103(1):11-18.
105. HOERAUF A, VOLKMANN L, HAMELMANN C et al.: Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet (2000) 355(9211):1242-1243.
106. JOHNSTON KL, TAYLOR MJ: Wolbachia in filarial parasites: targets for filarial infection and disease control. Curr. Infect. Dis. Rep. (2007) 9(1):55-59.
107. TOWNSON S, TAGBOTO S, MCGARRY HF et al.: Onchocerca parasites and Wolbachia endosymbionts: evaluation of a spectrum of antibiotic types for activity against Onchocerra gutturosa in vitro. Filaria J. (2006) 5:4.
108. TAYLOR MJ, MAKUNDE WH, MCGARRY HF et al.: Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial. Lancet (2005) 365:2116-2121.
109. TAYLOR MJ, HOERAUF A: A new approach to the treatment of filariasis. Curr. Opin. Infect. Dis. (2001) 14:727-731.
110. HOERAUF A, MAND S, FISCHER K et al.: Doxycycline as a novel strategy against bancroftian filariasis - depletion of Wolbachia endosymbionts from Wucherrria bancrofti and stop of microfilariae production. Med. Microbiol. Immunol. (2003) 192:211-216.
111. TURNER JD, MAND S, DEBRAH AY et al.: A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection. Clin. Infect. Dis. (2006) 42:1081-1089.
112. DEBRAH AY, MAND S, SPECHT S et al.: Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathogens (2006) 2(9):829-843.
113. TAYLOR MJ, CROSS HF, BILO K: Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria. J. Exp. Med. (2000) 191:1429-1436.
114. LOISEAU PM, BOURASS J, LETOURNEUX Y: Lymphotropic antifilarial agents derived from closantel and chlorambucil. Int. J. Parasitol. (1997) 27(4):443-447.
115. AWADZI K, ATTAH SK, ADDY ET et al.: Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. (2004) 98:359-370.
116. DAYAN AD: Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop. (2003) 86(2-3):141-159.
117. ISMAIL MM, JAYAKODY RL, WEIL GJ et al.: Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filiariasis. Trans. R. Soc. Trop. Med. Hyg. (1998) 92:94-97.
118. OTTESEN EA, ISMAIL MM, HORTON J: The role of albendazole in programs to eliminate lymphatic filariasis. Parasitol. Today (1999) 15:382-386.
119. MAK JW, NAVARATNAM V, RAMACHANDRAN CP: Experimental chemotherapy of lymphatic filariasis. A review. Ann. Trop. Med. Parasitol. (1991) 85(1):131-137.
120. RASTOGI S, KULSHRESHTHA DK, RAWAT AKS: Streblus asper Lour. (Shakhotaka): a review of its chemical, pharmacological and ethnomedicinal properties. Evid. Based Complement. Alternat. Med. (2006) 3(2):217-222.
121. COTREAU MM, WARRENS, RYAN JL et al.: The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans. J. Clin. Pharmacol. (2003) 43:1108-1115.
122. DREYER G, OTTESEN EA, GALDINO E et al.: Renal abnormalities in microfilaremic patients with Bancroftian filariasis. Am. J. Trop. Med. Hyg. (1992) 191:745-751.
123. LAMMIE PJ: The promise of Wolbarhia-targeted chemotherapy as a public health intervention for lymphatic filiriasis and onchocerciasis. Clin. Infect. Dis. (2006) 42:1090-1092.
124. GILBERT J, NFON CK, MAKEPEACE BL et al.: Antibiotic chemotherapy of onchocerciasis: in a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species). J. Infect. Dis. (2005) 191:1483-1493.
125. BAJPAI P, VEDI S, OWAIS M et al.: Use of liposmized tetracycline in elimination of Wolbachia endobacterium of human lymphatic filariid Brugia malayi in a rodent model. J. Drug Target (2005) 191:375-381.